MimoVac

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMimoVac
Drug Alias NameMimoVac breast cancer vaccine (Biolife Science)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiolife Science Qld Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolife Science Qld Ltd
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A